IRIS PubliCatt

Baranello, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.507
NA - Nord America 1.382
AS - Asia 502
AF - Africa 12
SA - Sud America 8
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.367
DE - Germania 635
SE - Svezia 229
SG - Singapore 184
CN - Cina 177
IT - Italia 145
IE - Irlanda 94
UA - Ucraina 93
FR - Francia 86
GB - Regno Unito 76
ID - Indonesia 58
RU - Federazione Russa 40
IN - India 34
FI - Finlandia 30
BE - Belgio 21
TR - Turchia 14
MK - Macedonia 12
RS - Serbia 12
CA - Canada 9
CH - Svizzera 9
HK - Hong Kong 9
NL - Olanda 8
CI - Costa d'Avorio 5
EG - Egitto 5
IR - Iran 5
KR - Corea 5
PA - Panama 5
PL - Polonia 5
BR - Brasile 4
CZ - Repubblica Ceca 4
IL - Israele 4
LT - Lituania 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
DK - Danimarca 1
ES - Italia 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
SC - Seychelles 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.416
Salva come PNG Salva come JPEG
Città #
Chandler 311
Singapore 147
Ashburn 106
New York 100
Dublin 77
Jacksonville 67
Jakarta 58
Ann Arbor 55
San Mateo 47
Nürnberg 40
Dearborn 38
Marseille 36
Wilmington 34
Nanjing 33
Seattle 33
Milan 31
Boston 25
Moscow 25
Rome 25
Munich 23
Woodbridge 21
Princeton 20
Brussels 18
Houston 18
Fairfield 17
Lancaster 17
Bremen 16
Los Angeles 16
Beijing 15
Nanchang 15
Augusta 12
Lawrence 12
Palermo 12
Paris 11
Leawood 10
Pune 10
Redwood City 10
Skopje 10
Hangzhou 9
Norwalk 9
Changsha 8
Hebei 8
Hong Kong 8
London 8
Chicago 7
Jinan 7
Boardman 6
Cambridge 6
Fremont 6
Hefei 6
Helsinki 6
Jiaxing 6
Menlo Park 6
Ningbo 6
Niš 6
Abidjan 5
Cattolica 5
Izmir 5
Shenyang 5
Washington 5
Amsterdam 4
Belgrade 4
Bern 4
Buffalo 4
Frankfurt am Main 4
Harrisburg 4
Kish 4
Lappeenranta 4
Seoul 4
Tianjin 4
Zhengzhou 4
Basel 3
Brno 3
Busto Arsizio 3
Cairo 3
Dallas 3
Detroit 3
Easton 3
Edinburgh 3
Guangzhou 3
Kiel 3
Kunming 3
Lima 3
Mountain View 3
South Hadley 3
Toronto 3
University Park 3
Andover 2
Ankara 2
Ashdod 2
Atlanta 2
Auckland 2
Bauang 2
Calgary 2
Cinisello Balsamo 2
Costa Mesa 2
Delianuova 2
Florence 2
Genoa 2
Istanbul 2
Totale 1.832
Salva come PNG Salva come JPEG
Nome #
Cortical visual function in preterm infants in the first year. 210
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 166
Prognostic value of EEG performed at term age in preterm infants. 156
-Thalamic atrophy in infants with PVL and cerebral visual impairment 140
Visual development in prenatal post-haemorragic ventricular dilatation 129
External hydrocephalus in discordant birth weight twins: a case report 125
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 123
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 118
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 115
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 104
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 100
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 98
antenatal post hemorrhagic ventriculomegaly: a prospective follow up study 87
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 86
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 81
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 76
Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data. 76
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 74
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 73
6 minute walk test in duchenne MD patients with different mutations:12 month changes 70
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 70
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 69
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 68
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 65
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 61
Longitudinal natural history in young boys with Duchenne muscular dystrophy 60
Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment? 59
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 58
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 53
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 53
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 52
The nonsense mutation stop+4 model correlates with motor changes in Duchenne muscular dystrophy 52
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 50
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 48
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 43
Risdiplam in Type 1 Spinal Muscular Atrophy 39
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 36
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 31
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 30
Development of an International SMA Bulbar Assessment for Inter-professional Administration 30
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 26
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls 22
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 20
The emerging spectrum of neurodevelopmental comorbidities in early-onset Spinal Muscular Atrophy 19
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial 18
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 17
Longitudinal data of neuropsychological profile in a cohort of Duchenne muscular dystrophy boys without cognitive impairment 15
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 15
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 13
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 13
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 11
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 10
Visual development in infants with prenatal posthaemorrhagic ventricular dilatation 7
Severe abnormalities of the pons in two infants with Goldenhar syndrome 7
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 7
Cognitive profile in Duchenne muscular dystrophy boys without intellectual disability: The role of executive functions 6
Visual findings in infants with periventricular leukomalacia: 139 5
The neurological examination of the newborn baby 4
Totale 3.469
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020255 0 0 0 0 33 41 55 10 30 23 43 20
2020/2021211 19 25 3 18 18 13 31 5 29 16 31 3
2021/2022384 19 17 19 41 25 15 7 64 29 23 61 64
2022/2023931 104 124 59 144 54 112 45 79 136 10 40 24
2023/2024610 31 126 18 39 21 132 59 18 5 23 63 75
2024/2025295 24 25 97 43 106 0 0 0 0 0 0 0
Totale 3.469